Abstract
e15569 Background: SmRCC is a rare variant of RCC associated with poor outcome. No definitive treatments exist. Expression of IMP3, a member of insulin-like growth factor-II mRNA binding protein, h...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
